Hillerød, Denmark, March 2025 – Ellab, a global leader in validation, monitoring, and calibration services and solutions, has officially announced the appointment of Gergely Sved as its new Chief Executive Officer (CEO). He will take charge in June 2025, succeeding Ludvig Enlund, with Chief Financial Officer Andreas Morthorst serving as interim CEO until Mr. Sved assumes the role.
Mr. Sved is a seasoned executive in the healthcare and life sciences industry. He most recently served as Executive Vice President and Group President for the Healthcare and Life Sciences division at Ecolab Inc, where he led ambitious growth strategies in Cleanroom, API, and Bioprocessing businesses. During his tenure, he also oversaw the expansion of Ecolab’s Endoscopy, Surgical, and Infection Prevention divisions, including during the height of the COVID-19 pandemic.
Before joining Ecolab, Mr. Sved had a 23-year career at General Electric, culminating in his role as Vice President and General Manager for Europe Services at GE Healthcare. His extensive leadership experience across complex, regulated industries positions him well to guide Ellab’s next chapter of strategic growth.
Anders Hedegaard, Chair of Ellab, remarked, “Ellab is at a very exciting point in time as we look to accelerate growth and development of the business. Gergely brings a wealth of relevant experience, and we look forward to working with him as we execute our ambitious growth strategy. We are grateful for Ludvig’s contribution to bringing Ellab to where we are today and wish him well in his onwards career.”
Commenting on his appointment, Gergely Sved said, “Ellab is a fascinating business that plays a critical role in ensuring integrated compliance solutions, anchored in its customers’ most critical operations. It has great products and services, and a highly experienced team, and I am looking forward to working together to help Ellab fulfil its tremendous potential.”
About Ellab
Founded in 1949, Ellab serves the life sciences industry by providing advanced validation, monitoring, and calibration solutions designed to ensure product integrity and regulatory compliance. Following its acquisition by Novo Holdings and The Lundbeck Foundation in 2023, Ellab has scaled its global footprint to meet growing industry demands. Operating in over 40 countries with a workforce of around 800 professionals, Ellab is committed to excellence in compliance technology and service support across critical life science applications.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
